Topic Dossier

Economy

Merck Acquires Terns for $6.7 Billion to Expand Cancer Portfolio

First article: 25 mar. 2026, 20:54 | Last update: 25 mar. 2026, 20:54 | 1 source | 1 article
#merger#acquisition#pharmaceutical#cancer

Multiple sources. Less manipulation.

Editorial Analysis

Based on 1 source, 1 article

Merck, a major pharmaceutical company, has announced its acquisition of Terns Pharmaceuticals for $6.7 billion. This strategic move is intended to strengthen Merck's position in the rapidly evolving field of blood cancer treatments. Terns Pharmaceuticals has been developing innovative therapies targeting various forms of blood cancer.

Articles about this topic

Avalanche in Swedish ski resort leaves multiple people trapped Foto: The Independent
The Independent Oisin Mcilroy 25 mar. 2026, 20:54 (2 hours ago) Good

Avalanche in Swedish ski resort leaves multiple people trapped

The incident prompted a significant emergency services response, including assistance from Norway

Read on The Independent →